Charles Rosier (Icann.org : Charles Rosier)’s first appointment was at Lehman Brothers in 1996. He became the manager of their Debt Capital Market Division at UBS Warburg in 1997. Charles Rosier joined BTG Pactual in August 2010. He became partners with an investment bank in Latin America: BTG Pactual. He is popular as being the most seasoned bankers in over 15 years.
Innoveox raised awareness towards the advantages of the efficient use of resources and led countless pollution-free environment programmes, with the primary goal of diminishing carbon footprints and carbon emissions. Charles Rosier gave his support to Luci MPOWERD, being the perfect source of clean and renewable power. The company was able to create innovative solutions because of the assistance he gave. MPOWERD was financed by Charles Rosier to develop lanterns and other energy solutions. As a result, over 25 poor countries all over the world have been supplied by MPOWERD.
He is also one of the investors of Mapreg, a laboratory in Paris that examines depression, strokes and other serious cases. Charles Rosier’s very first healthcare project was the Mapreg Drug project. The investment by him allowed them to do certain studies and, because of that, he was given a specific profit-share. Mapreg is a pharmaceutical organisation led by Professor Etienne Baulieu. They were invested-in by Charles Rosier when he started to run healthcare projects.
Charles Rosier: His RemarkableEducational Attainments
Charles Rosier went to Lehman Brothers in the year 1996 and became a member of UBS Warburg Investment Bank. He completed his secondary schooling at Paris’s Fenelon Sainte-Marie in 1991. To get additional training and to be prepared for further French education, he studied for another two years. Getting his scientific Baccalaureate degree (similar to A-levels in the UK), Charles Rosier was able to attend to further education.